Brooks Cash, MD, chief of gastroenterology and hepatology at the University of Texas Health Center at Houston, will chair the board.
The board is charged with expanding the use of Biomerica’s EZ Detect product, an at-home test that identifies fecal occult blood. The group also will work to expand use of the test among underserved populations.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
